Hunan Jiudian Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300705.SZ

Hunan Jiudian Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 12.83%

Hunan Jiudian Pharmaceutical Co., Ltd. Return on Assets (ROA) is 12.83% for the year ending December 31, 2023, a 9.36% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Hunan Jiudian Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 11.73%, a 0.21% change year over year.
Hunan Jiudian Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 11.70%, a 60.87% change year over year.
Hunan Jiudian Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 7.27%, a 41.64% change year over year.
Hunan Jiudian Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 5.14%, a -32.70% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Shenzhen Stock Exchange: 300705.SZ

Hunan Jiudian Pharmaceutical Co., Ltd.

CEO	Mr. Yang Yang
IPO Date	Oct. 10, 2017
Location	China
Headquarters	Building A1, Shibuya Science and Technology Industrial Park
Employees	1,893
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers antiallergic, anti-infective, and anti-inflammatory drugs; analgosies and gynecological medication products; digestive system products; chemical and Chinese patent medicines; medical instruments; APIs; and other products. It also provides outsourcing services for tablets, capsules, granules, oral solutions, syrups, etc. Hunan Jiudian Pharmaceutical Co., Ltd. is based in Changsha, China.

Key trends

Past 5 years